Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Arnoud J. Templeton
Based on 21 articles published since 2009
(Why 21 articles?)
||||
Expertise Level
The expertise of Arnoud J. Templeton ranks in the
  • Top 0.27%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 21 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Templeton, Arnoud   ·   Templeton, Arnoud J   ·   Templeton, A J
Work Locations
Details
Most likely:    University of Basel      
2018
  • Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Medical Oncology, St Claraspital and Faculty of Medicine, University of Basel, Basel, Switzerland. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: · Pubmed 29126017
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
  • Institute for Clinical Chemistry and Haematology, St Gallen Cantonal Hospital, Switzerland. · Department of Medical Oncology and Haematology, St Gallen Cantonal Hospital, Switzerland. · Statistical Office, Swiss Group for Clinical Cancer Research Coordinating Centre - SAKK, Bern, Switzerland. · Oncology Centre, Männedorf Hospital, Zurich, Switzerland. · Department of Oncology and Haematology, Graubuenden Cantonal Hospital, Chur, Switzerland. · Breast Centre St Gallen, St Gallen Cantonal Hospital, Switzerland. · Department of Oncology, St Claraspital Basel and Faculty of Medicine, University of Basel, Switzerland. · Pubmed 29376548
2017
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 28881223
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Pubmed 28734183
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. · Department of Medical Oncology, St. Claraspital Basel and Faculty of Medicine, University of Basel, Basel, Switzerland. · Institute of Health Policy and Management Evaluation, University of Toronto, Toronto, Canada. · Department of Paediatrics, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Pubmed 28057046
Probable:    Miscellaneous institutions in Basel      
2018
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
2016
  • Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen, and Faculty of Medicine, University Basel, Switzerland. · Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Department of Oncology, Queen's University, Kingston, ON, Canada. · Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Centro de Investigación del Cáncer CIC-CSIC, Universidad de Salamanca, Salamanca, Spain. · Pubmed 27149669
Probable:    Miscellaneous institutions in St. Gallen      
2016
  • Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen, and Faculty of Medicine, University Basel, Switzerland. · Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Department of Oncology, Queen's University, Kingston, ON, Canada. · Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Centro de Investigación del Cáncer CIC-CSIC, Universidad de Salamanca, Salamanca, Spain. · Pubmed 27149669
  • Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · IBMCC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 26897635
2015
  • Department of Medical Oncology and Hematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26169770
2014
  • Breast Centre, St. Gallen, Switzerland. Electronic address: · IBCSG, Bern, Switzerland. · Spirig Pharma Schweiz and Dermatologische Universitätsklinik, Basel, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Medical Oncology, Spitalzentrum AG, Biel, Switzerland. · Medical Oncology, Kantonsspital Winterthur, Switzerland. · Medical Oncology, Kantonsspital Aarau, Aarau, Switzerland. · Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland. · Medical Oncology, Universitätsspital, Basel, Switzerland. · Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland. · Medical Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Breast Centre, St. Gallen, Switzerland. · Pubmed 24656636
2013
  • Breast Centre, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland. · Pubmed 23530694
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 21 total) written by Arnoud J. Templeton about Breast Neoplasms:

  • Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis. 2018
  • Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy. 2018
  • Vitamin D levels in Swiss breast cancer survivors. 2018
  • Reporting of Randomized Trials in Common Cancers in the Lay Media. 2018
  • Efficacy of extended adjuvant therapy with aromatase inhibitors in early breast cancer among common clinicopathologically-defined subgroups: A systematic review and meta-analysis. 2017
  • Influence of non-measurable disease on progression-free survival in patients with metastatic breast cancer. 2017
  • Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. 2017
  • Interaction between Hormonal Receptor Status, Age and Survival in Patients with BRCA1/2 Germline Mutations: A Systematic Review and Meta-Regression. 2016
  • Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer. 2016
  • Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer. 2015
Show List of Full Article Records
Google Searches

Learn more about Arnoud J. Templeton using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Basel
Miscellaneous institutions in Basel
Miscellaneous institutions in St. Gallen
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Basel
2018
  • Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. · Department of Medical Oncology, St Claraspital and Faculty of Medicine, University of Basel, Basel, Switzerland. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Centro Universitario Contra el Cáncer, Hospital Universitario, Universidad Autónoma de Nuevo León, Monterrey, Mexico; Canadian Cancer Trials Group, Department of Medical Oncology, Faculty of Medicine, Queen's University, Kingston, Ontario, Canada. Electronic address: · Pubmed 29126017
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
  • Institute for Clinical Chemistry and Haematology, St Gallen Cantonal Hospital, Switzerland. · Department of Medical Oncology and Haematology, St Gallen Cantonal Hospital, Switzerland. · Statistical Office, Swiss Group for Clinical Cancer Research Coordinating Centre - SAKK, Bern, Switzerland. · Oncology Centre, Männedorf Hospital, Zurich, Switzerland. · Department of Oncology and Haematology, Graubuenden Cantonal Hospital, Chur, Switzerland. · Breast Centre St Gallen, St Gallen Cantonal Hospital, Switzerland. · Department of Oncology, St Claraspital Basel and Faculty of Medicine, University of Basel, Switzerland. · Pubmed 29376548
2017
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON M5G 2M9, Canada. Electronic address: · Pubmed 28881223
  • Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada; Sackler Faculty of Medicine, Tel Aviv University, POB 39040, Tel Aviv 6997801, Israel. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Department of Medical Oncology, Institute of Oncology Ljubljana, 2 Zaloska cesta, Ljubljana 1000, Slovenia. Electronic address: · Department of Oncology and Hematology, St. Claraspital, Faculty of Medicine, University of Basel, Kleinriehenstrasse 30, Basel 4058, Switzerland. Electronic address: · Translational Research Unit, Centro Regional de Investigaciones Biomedicas Universidad de Castilla La Mancha, Albacete University Hospital, calle Francisco Javier de Moya 02006, Albacete, Spain. Electronic address: · Division of Medical Oncology, University of Toronto and Princess Margaret Cancer Centre, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Electronic address: · Pubmed 28734183
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. · Department of Medical Oncology, St. Claraspital Basel and Faculty of Medicine, University of Basel, Basel, Switzerland. · Institute of Health Policy and Management Evaluation, University of Toronto, Toronto, Canada. · Department of Paediatrics, Mount Sinai Hospital, University of Toronto, Toronto, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue 5-124, Toronto, ON, M5G 2M9, Canada. · Department of Medicine, University of Toronto, Toronto, Canada. · Pubmed 28057046
Miscellaneous institutions in Basel
2018
  • Department of Medical Oncology, St. Claraspital, Basel, Switzerland. · Faculty of Medicine, University of Basel, Basel, Switzerland. · Hospital Universitario de Elche, Elche, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Instituto Valenciano de Oncología, Valencia, Spain. · Hospital Virgen de la Victoria, Málaga, Spain. · Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. · Complejo Hospitalario Juan Canalejo, A Coruña, Spain. · Hospital Univ. Virgen del Rocío, Seville, Spain. · Hospital Universitario La Fe, Valencia, Spain. · Hospital Clínico Universitario de Salamanca, Salamanca (IBSAL), Salamanca, Spain. · Hospital Ramón y Cajal, Madrid, Spain. · Centro Oncológico de Galicia, A Coruña, Spain. · Hospital de Cabueñes, Gijón, Spain. · Biomedical Research Institute INCLIVA, Hospital Clínico Universitario de Valencia, University of Valencia, Valencia, Spain. · Hospital de Donostia, San Sebastián, Spain. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada. · Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain. · GEICAM (Spanish Breast Cancer Group), Madrid, Spain. · Complejo Hospitalario Universitario de Albacetee, Centro Regional de Investigaciones Biomédicas, Universidad de Castilla la Mancha, Albacete, Spain. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Edificio de Investigación, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Pubmed 29766456
2016
  • Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen, and Faculty of Medicine, University Basel, Switzerland. · Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Department of Oncology, Queen's University, Kingston, ON, Canada. · Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Centro de Investigación del Cáncer CIC-CSIC, Universidad de Salamanca, Salamanca, Spain. · Pubmed 27149669
Miscellaneous institutions in St. Gallen
2016
  • Department of Medical Oncology, Kantonsspital St. Gallen, St. Gallen, and Faculty of Medicine, University Basel, Switzerland. · Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Department of Oncology, Queen's University, Kingston, ON, Canada. · Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau and Universitat Autònoma de Barcelona, Barcelona, Spain. · Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Department of Medical Oncology, Institute of Oncology, Ljubljana, Slovenia. · Centro de Investigación del Cáncer CIC-CSIC, Universidad de Salamanca, Salamanca, Spain. · Pubmed 27149669
  • Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Translational Research Unit, Albacete University Hospital, Calle Francisco Javier de Moya, 02006, Albacete, Spain. · Department of Medical Oncology and Hematology, Kantonsspital St. Gallen, St. Gallen, Switzerland. · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · IBMCC, CSIC-University of Salamanca, Salamanca, Spain. · Pubmed 26897635
2015
  • Department of Medical Oncology and Hematology, Kantonsspital St Gallen, St Gallen, Switzerland · Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26169770
2014
  • Breast Centre, St. Gallen, Switzerland. Electronic address: · IBCSG, Bern, Switzerland. · Spirig Pharma Schweiz and Dermatologische Universitätsklinik, Basel, Switzerland. · Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Medical Oncology, Spitalzentrum AG, Biel, Switzerland. · Medical Oncology, Kantonsspital Winterthur, Switzerland. · Medical Oncology, Kantonsspital Aarau, Aarau, Switzerland. · Medical Oncology, Luzerner Kantonsspital, Luzern, Switzerland. · Medical Oncology, Universitätsspital, Basel, Switzerland. · Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland. · Medical Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland. · Breast Centre, St. Gallen, Switzerland. · Pubmed 24656636
2013
  • Breast Centre, Rorschacherstrasse 95, 9007, St. Gallen, Switzerland. · Pubmed 23530694
University Health Network of Toronto
2015
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology, University Hospital, Albacete, Spain. · Department of Oncology, McMaster University, Hamilton, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 25728257
  • Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Pubmed 26283612
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
  • Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. · Department of Medical Oncology, Institute of Oncology Ljubljana, Slovenia. · IBMCC-CSIC, Universidad de Salamanca, Spain. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. Electronic address: · Pubmed 25217796
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada ; Ministry of Higher Education, Riyadh, Saudi Arabia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 24586311
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
2018
  • Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Cancer Centre, Toronto, ON, Canada. · Pubmed 29151109
2014
  • Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada, · Pubmed 24928527
University of Toronto
2015
  • Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada. · Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 26076967
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology, University Hospital, Albacete, Spain. · Department of Oncology, McMaster University, Hamilton, Canada. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 25728257
  • Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Princess Margaret Cancer Center, University of Toronto, Toronto, Canada (AO, FVB, AT, IT, EA). · Pubmed 26283612
2014
  • Affiliations of authors: Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (FEV-B, AJT, PdG, ID-P, PLB, MA-M, IFT, AO, EA) · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia (BS) · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain (AO). · Pubmed 24273215
  • Divisions of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. · Department of Medical Oncology, Institute of Oncology Ljubljana, Slovenia. · IBMCC-CSIC, Universidad de Salamanca, Spain. · Translational Oncology Unit, Albacete University Hospital, Albacete, Spain. Electronic address: · Pubmed 25217796
  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada ; Ministry of Higher Education, Riyadh, Saudi Arabia. · Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre and Department of Medicine, University of Toronto, Toronto, Canada. · Medical Oncology Department and Translational Research Unit, Albacete University Hospital, Albacete, Spain. · Sector of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. · Pubmed 24586311
2012
  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, Department of Medicine, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada. · Pubmed 22956007
2018
  • Division of Medical Oncology and Hematology, University of Toronto and Princess Margaret Cancer Centre, Toronto, ON, Canada. · Pubmed 29151109
Miscellaneous institutions in Albacete
2013
  • Translational Research Unit and Medical Oncology Department, Albacete University Hospital, Albacete, Spain. · Pubmed 23221996
Yearly article counts 04324521000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.